vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and IPG PHOTONICS CORP (IPGP). Click either name above to swap in a different company.
IPG PHOTONICS CORP is the larger business by last-quarter revenue ($274.5M vs $196.0M, roughly 1.4× Axsome Therapeutics, Inc.). IPG PHOTONICS CORP runs the higher net margin — 4.8% vs -14.6%, a 19.4% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 17.1%). IPG PHOTONICS CORP produced more free cash flow last quarter ($10.9M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 4.4%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
IPG Photonics Corporation is a manufacturer of fiber lasers. IPG Photonics developed and commercialized optical fiber lasers, which are used in a variety of applications including materials processing, medical applications and telecommunications. IPG has manufacturing facilities in the United States, Germany, Russia and Italy.
AXSM vs IPGP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $274.5M |
| Net Profit | $-28.6M | $13.3M |
| Gross Margin | — | 36.1% |
| Operating Margin | -13.8% | 1.2% |
| Net Margin | -14.6% | 4.8% |
| Revenue YoY | 65.0% | 17.1% |
| Net Profit YoY | 61.9% | 69.8% |
| EPS (diluted) | $-0.55 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $274.5M | ||
| Q3 25 | $171.0M | $250.8M | ||
| Q2 25 | $150.0M | $250.7M | ||
| Q1 25 | $121.5M | $227.8M | ||
| Q4 24 | $118.8M | $234.3M | ||
| Q3 24 | $104.8M | $233.1M | ||
| Q2 24 | $87.2M | $257.6M | ||
| Q1 24 | $75.0M | $252.0M |
| Q4 25 | $-28.6M | $13.3M | ||
| Q3 25 | $-47.2M | $7.5M | ||
| Q2 25 | $-48.0M | $6.6M | ||
| Q1 25 | $-59.4M | $3.8M | ||
| Q4 24 | $-74.9M | $7.8M | ||
| Q3 24 | $-64.6M | $-233.6M | ||
| Q2 24 | $-79.3M | $20.2M | ||
| Q1 24 | $-68.4M | $24.1M |
| Q4 25 | — | 36.1% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 39.4% | ||
| Q4 24 | — | 38.6% | ||
| Q3 24 | — | 23.2% | ||
| Q2 24 | — | 37.3% | ||
| Q1 24 | — | 38.7% |
| Q4 25 | -13.8% | 1.2% | ||
| Q3 25 | -27.0% | 3.1% | ||
| Q2 25 | -24.5% | 0.0% | ||
| Q1 25 | -46.9% | 0.8% | ||
| Q4 24 | -61.1% | 6.0% | ||
| Q3 24 | -59.8% | -108.7% | ||
| Q2 24 | -89.5% | 4.7% | ||
| Q1 24 | -89.7% | 7.6% |
| Q4 25 | -14.6% | 4.8% | ||
| Q3 25 | -27.6% | 3.0% | ||
| Q2 25 | -32.0% | 2.6% | ||
| Q1 25 | -48.9% | 1.6% | ||
| Q4 24 | -63.1% | 3.3% | ||
| Q3 24 | -61.7% | -100.2% | ||
| Q2 24 | -91.0% | 7.8% | ||
| Q1 24 | -91.1% | 9.6% |
| Q4 25 | $-0.55 | $0.30 | ||
| Q3 25 | $-0.94 | $0.18 | ||
| Q2 25 | $-0.97 | $0.16 | ||
| Q1 25 | $-1.22 | $0.09 | ||
| Q4 24 | $-1.54 | $0.27 | ||
| Q3 24 | $-1.34 | $-5.33 | ||
| Q2 24 | $-1.67 | $0.45 | ||
| Q1 24 | $-1.44 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $839.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $2.1B |
| Total Assets | $689.8M | $2.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $839.3M | ||
| Q3 25 | $325.3M | $870.4M | ||
| Q2 25 | $303.0M | $899.6M | ||
| Q1 25 | $300.9M | $926.9M | ||
| Q4 24 | $315.4M | $930.2M | ||
| Q3 24 | $327.3M | $1.0B | ||
| Q2 24 | $315.7M | $1.1B | ||
| Q1 24 | $331.4M | $1.1B |
| Q4 25 | $88.3M | $2.1B | ||
| Q3 25 | $73.7M | $2.1B | ||
| Q2 25 | $73.1M | $2.1B | ||
| Q1 25 | $53.2M | $2.1B | ||
| Q4 24 | $57.0M | $2.0B | ||
| Q3 24 | $92.9M | $2.1B | ||
| Q2 24 | $102.9M | $2.3B | ||
| Q1 24 | $144.0M | $2.3B |
| Q4 25 | $689.8M | $2.4B | ||
| Q3 25 | $669.3M | $2.4B | ||
| Q2 25 | $639.8M | $2.4B | ||
| Q1 25 | $596.7M | $2.3B | ||
| Q4 24 | $568.5M | $2.3B | ||
| Q3 24 | $561.5M | $2.4B | ||
| Q2 24 | $548.2M | $2.5B | ||
| Q1 24 | $545.7M | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $28.8M |
| Free Cash FlowOCF − Capex | $-18.7M | $10.9M |
| FCF MarginFCF / Revenue | -9.6% | 4.0% |
| Capex IntensityCapex / Revenue | 0.0% | 6.5% |
| Cash ConversionOCF / Net Profit | — | 2.17× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $-3.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $28.8M | ||
| Q3 25 | $1.0M | $35.3M | ||
| Q2 25 | $-32.4M | $-2.2M | ||
| Q1 25 | $-43.4M | $13.4M | ||
| Q4 24 | $-26.2M | $73.8M | ||
| Q3 24 | $-18.6M | $66.1M | ||
| Q2 24 | $-30.1M | $53.5M | ||
| Q1 24 | $-53.5M | $54.6M |
| Q4 25 | $-18.7M | $10.9M | ||
| Q3 25 | $988.0K | $14.6M | ||
| Q2 25 | $-32.4M | $-17.6M | ||
| Q1 25 | $-43.7M | $-11.4M | ||
| Q4 24 | $-26.2M | $50.6M | ||
| Q3 24 | $-18.7M | $43.0M | ||
| Q2 24 | $-30.2M | $29.2M | ||
| Q1 24 | $-53.6M | $26.5M |
| Q4 25 | -9.6% | 4.0% | ||
| Q3 25 | 0.6% | 5.8% | ||
| Q2 25 | -21.6% | -7.0% | ||
| Q1 25 | -36.0% | -5.0% | ||
| Q4 24 | -22.1% | 21.6% | ||
| Q3 24 | -17.9% | 18.4% | ||
| Q2 24 | -34.6% | 11.3% | ||
| Q1 24 | -71.4% | 10.5% |
| Q4 25 | 0.0% | 6.5% | ||
| Q3 25 | 0.0% | 8.3% | ||
| Q2 25 | 0.0% | 6.1% | ||
| Q1 25 | 0.3% | 10.9% | ||
| Q4 24 | 0.0% | 9.9% | ||
| Q3 24 | 0.1% | 9.9% | ||
| Q2 24 | 0.1% | 9.4% | ||
| Q1 24 | 0.1% | 11.1% |
| Q4 25 | — | 2.17× | ||
| Q3 25 | — | 4.73× | ||
| Q2 25 | — | -0.34× | ||
| Q1 25 | — | 3.58× | ||
| Q4 24 | — | 9.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.65× | ||
| Q1 24 | — | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
IPGP
| Materials Processing | $232.8M | 85% |
| Laser And Non Laser Systems | $38.8M | 14% |
| Transferred Over Time | $5.3M | 2% |
